Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo controlled trial in asymptomatic antiphospholipid antibody-positive individuals.

Erkan, Doruk, Harrison, Melanie J., Levy, Roger, Peterson, Margaret, Petri, Michelle, Sammaritano, Lisa, Unalp‐Arida, Aynur, Vilela, Veronica +2 more·2007·Arthritis & Rheumatism
DOI 10.1002/art.22663

Cited by (398)

Items 101–200 of 398

  1. Recurrent Miscarriage, Antiphospholipid Antibodies and the Risk of Thromboembolic Disease
    Maria Ángeles Martínez‐Zamora, Ricard Cervera, Juan Balasch · 2012 · Clinical Reviews in Allergy & Immunology
  2. Antiphospholipid syndrome dilemmas still to be solved: 2008 status
    Yehuda Shoenfeld, Pier Luigi Meroni, Ricard Cervera · 2008 · Annals of the Rheumatic Diseases
  3. Aspirin and multiple sclerosis
    Sheila Tsau, Mitchell R. Emerson, SHARON G. LYNCH, Steven M. LeVine · 2015 · BMC Medicine
  4. Postpartum evaluation and long term implications
    Tabassum Firoz, Tanya E. Melnik · 2011 · Best Practice & Research Clinical Obstetrics & Gynaecology
  5. Treatment of antiphospholipid syndrome
    Massimo Radin, Irene Cecchi, Elena Rubini, Silvia Grazietta Foddai, Alice Barinotti, Elisa Menegatti, Dario Roccatello, Savino Sciascia · 2020 · Clinical Immunology
  6. New targeted therapies for treatment of thrombosis in antiphospholipid syndrome
    Silvia S. Pierangeli, Mariano E. Vega-Ostertag, Emilio B. González · 2007 · Expert Reviews in Molecular Medicine
  7. The Antiphospholipid Syndrome
    David P. D’Cruz, Munther A. Khamashta · 2009 · Springer eBooks
  8. Cognitive dysfunction and white matter abnormalities in antiphospholipid syndrome
    Doruk Erkan, Elizabeth Kozora, Michael D. Lockshin · 2010 · Pathophysiology
  9. Diagnosis and treatment of antiphospholipid syndrome in childhood: A review
    Dax G. Rumsey, Barry Lee Myones, Patti Massicotte · 2017 · Blood Cells Molecules and Diseases
  10. Aspirin for Primary Prevention of Cardiovascular Disease in the 21st Century: A Review of the Evidence
    Dominick Joseph Angiolillo, Davide Capodanno · 2021 · The American Journal of Cardiology
  11. The Journey of Antiphospholipid Antibodies From Cellular Activation to Antiphospholipid Syndrome
    Rohan Willis, E. B. Gonzalez, Allan R. Brasier · 2015 · Current Rheumatology Reports
  12. Update on Antiphospholipid Syndrome: Ten Topics in 2017
    Ilaria Cavazzana, Laura Andréoli, M. A. Limper, Franco Franceschini, Anǵela Tincani · 2018 · Current Rheumatology Reports
  13. Primary Prevention of Cardiovascular Events with Aspirin: Toward More Harm than Benefit—A Systematic Review and Meta-Analysis
    Mikael Christiansen, Erik Lerkevang Grove, Anne‐Mette Hvas · 2019 · Seminars in Thrombosis and Hemostasis
  14. Monitoring the hydrolyzation of aspirin during the dissolution testing for aspirin delayed-release tablets with a fiber-optic dissolution system
    Yan Wang, Ping-Ping Xu, Xin-Xia Li, Kun Nie, Ming-Fu Tuo, Bin Kong, Jian Chen · 2012 · Journal of Pharmaceutical Analysis
  15. Thrombotic Microangiopathy in Pregnancy: Current Understanding and Management Strategies
    Manuel Urra, Shannon Lyons, Corina Gabriela Teodosiu, Richard M. Burwick, Anuja Java · 2024 · Kidney International Reports
  16. Prevention and management of co-morbidities in SLE
    Tanmayee Bichile, Michelle Petri · 2014 · La Presse Médicale
  17. Thromboprophylaxis in carriers of antiphospholipid antibodies (APL) without previous thrombosis: “Pros” and “Cons”
    Fulvia Ceccarelli, Cecilia Beatrice Chighizola, Guido Finazzi, Pier Luigi Meroni, Guido Valesini · 2011 · Autoimmunity Reviews
  18. ASH evidence-based guidelines: should asymptomatic patients with antiphospholipid antibodies receive primary prophylaxis to prevent thrombosis?
    Ara D. Metjian, Wendy Lim · 2009 · Hematology
  19. Long-term trends in antithrombotic drug prescriptions among adults aged 80 years and over from primary care: a temporal trends analysis using electronic health records
    Alex Dregan, Rathi Ravindrarajah, Judith Charlton, Mark J. Ashworth, Mariam Molokhia · 2018 · Annals of Epidemiology
  20. Recognition and management of antiphospholipid syndrome
    Maria Gerosa, Pier Luigi Meroni, Doruk Erkan · 2015 · Current Opinion in Rheumatology
  21. Cutaneous manifestations of antiphospholipid syndrome: a review of the clinical features, diagnosis and management.
    Teresa Pinto‐Almeida, Mónica Caetano, Madalena Sanches, Manuela Selores · 2013 · PubMed
  22. Recomendaciones de la Sociedad Española de Reumatología sobre síndrome antifosfolípido primario. Parte I: Diagnóstico, evaluación y tratamiento
    Rafael Cáliz, Petra Díaz del Campo Fontecha, María Galindo-Izquierdo, Francisco Javier López Longo, María Ángeles Martínez Zamora, Amparo Santamaría, Olga Amengual Pliego, María José Cuadrado Lozano, María Paloma Delgado Beltrán, Loreto Carmona et al. · 2019 · Reumatología Clínica
  23. The chequered history of the antiphospholipid syndrome
    Deepa J. Arachchillage, Mike Greaves · 2014 · British Journal of Haematology
  24. Prevention of thrombosis in antiphospholipid syndrome
    Wendy Lim · 2016 · Hematology
  25. Aspirin for the primary prevention of cardiovascular disease: latest evidence
    Davide Capodanno, Salvatore Ingala, Dario Calderone, Dominick Joseph Angiolillo · 2019 · Expert Review of Cardiovascular Therapy
  26. Low Molecular Weight Heparin in Obstetric Care: A Review of the Literature
    Silvia D’Ippolito, Amparo Santamaría, Manuela Veglia, Chiara Tersigni, Nicoletta Di Simone · 2011 · Reproductive Sciences
  27. β 2 -Glycoprotein I/IgA Immune Complexes
    Manuel Serrano, José A. Martínez-Flores, María Dolores Pérez, Florencio García, Oscar Cabrera, Daniel Enrique Pleguezuelo, Estela Paz‐Artal, José M. Morales, Esther González, Antonio Serrano · 2017 · Circulation
  28. Primary Thrombosis Prophylaxis in Persistently Antiphospholipid Antibody-Positive Individuals: Where Do We Stand in 2018?
    Yu Zuo, Medha Barbhaiya, Doruk Erkan · 2018 · Current Rheumatology Reports
  29. Managing Antiphospholipid Syndrome in Children and Adolescents: Current and Future Prospects
    Aline Garcia Islabão, Vítor Cavalcanti da Trindade, Lícia Maria Henrique da Mota, DANIELI CASTRO OLIVEIRA DE ANDRADE, Clóvis A. Silva · 2021 · Pediatric Drugs
  30. Risk of Thromboembolism in Patients with Immune Thrombocytopenia
    2015 · Journal of Hematology & Thromboembolic Diseases
  31. The Future of Antiphospholipid Antibody Testing
    Philip G. de Groot, Rolf T. Urbanus · 2012 · Seminars in Thrombosis and Hemostasis
  32. Elevated serum antiphospholipid antibodies in adults with celiac disease
    Outi Laine, Katariina Pitkänen, Katri Lindfors, Heini Huhtala, Onni J Niemelä, Pekka Collin, Kalle Kurppa, Katri Kaukinen · 2017 · Digestive and Liver Disease
  33. Controversies in the antiphospholipid syndrome: can we ever stop warfarin?
    Ana Glória Fonseca, David P. D’Cruz · 2008 · Journal of Autoimmune Diseases
  34. Antiphospholipid antibodies during infectious mononucleosis and their long term clinical significance
    Eli Ben‐Chetrit, Yonit Weil‐Weiner, Ayman Fadeela, Dana G. Wolf · 2013 · Journal of Clinical Virology
  35. The wound/burn guidelines – 4: Guidelines for the management of skin ulcers associated with connective tissue disease/vasculitis
    Manabu Fujimoto, Yoshihide Asano, Takayuki Ishii, Fumihide Ogawa, Tamihiro Kawakami, Masanari Kodera, Masatoshi Abe, Taiki Isei, Takaaki Ito, Yuji Inoue et al. · 2016 · The Journal of Dermatology
  36. Management of Women with Antiphospholipid Antibodies or Antiphospholipid Syndrome during Pregnancy
    Eunyoung Emily Lee, Jong Kwan Jun, Eun Bong Lee · 2021 · Journal of Korean Medical Science
  37. Evolution of Antiphospholipid Syndrome
    Deepa J. Arachchillage, Charis Pericleous · 2023 · Seminars in Thrombosis and Hemostasis
  38. Diretrizes para o tratamento da síndrome do anticorpo antifosfolipídeo
    Adriana Danowski, Jozélia Rêgo, Adriana María Kakehasi, Andreas Funke, Jozélio Freire de Carvalho, Isabella Lima, Alexandre Wagner Silva de Souza, Roger A. Levy · 2013 · Revista Brasileira de Reumatologia
  39. Preclinical and early systemic lupus erythematosus
    Mariele Gatto, Francesca Saccon, Margherita Zen, Luca Iaccarino, Andrea Doria · 2019 · Best Practice & Research Clinical Rheumatology
  40. Primary prevention in antiphospholipid antibody carriers
    MT Bertero · 2012 · Lupus
  41. Recent advances in understanding antiphospholipid syndrome
    María Laura Bertolaccini, Giovanni Sanna · 2016 · F1000Research
  42. Guidelines for the treatment of antiphospholipid syndrome
    Adriana Danowski, Jozélia Rêgo, Adriana María Kakehasi, Andreas Funke, Jozélio Freire de Carvalho, Isabella Lima, Alexandre Wagner Silva de Souza, Roger A. Levy · 2013 · Revista Brasileira de Reumatologia (English Edition)
  43. Venous thromboembolic disease in systemic autoimmune diseases: An association to keep in mind
    Ricardo Silvariño, Ãlvaro Danza, Valentina Mérola, Adriana Bérez, Enrique Méndez, Gerard Espinosa, Ricard Cervera · 2012 · Autoimmunity Reviews
  44. Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? Yes (in some cases)
    Maria Gerosa, Cecilia Beatrice Chighizola, Pier Luigi Meroni · 2008 · Internal and Emergency Medicine
  45. Management of antiphospholipid syndrome
    Anisur Rahman · 2020 · Clinical Rheumatology
  46. Risk Factors for the Development of the Disease in Antiphospholipid Antibodies Carriers: A Long-term Follow-up Study
    Ruiz Quijano Pablo, Pedro Muñoz, Marcos López‐Hoyos, Vanesa Calvo-Río, Leyre Riancho‐Zarrabeitia, Víctor Manuel Martínez-Taboada · 2021 · Clinical Reviews in Allergy & Immunology
  47. Antiphospholipid Syndrome: State of the Art of Clinical Management
    Luca Depietri, Maria Rosaria Veropalumbo, Maria Cristina Leone, Angelo Ghirarduzzi · 2023 · Cardiovascular Drugs and Therapy
  48. How to diagnose and manage antiphospholipid syndrome
    Anne K. Hubben, Keith R. McCrae · 2023 · Hematology
  49. Primary thromboprophylaxis with low-dose aspirin and antiphospholipid antibodies: Pro's and Con's
    Laurent Arnaud, Fabrizio Conti, Laura Massaro, Gentian Denas, François Chasset, Vittorio Pengo · 2017 · Autoimmunity Reviews
  50. Which Hormones and Contraception for Women with APS? Exogenous Hormone Use in Women with APS
    Lisa R. Sammaritano · 2021 · Current Rheumatology Reports
  51. Thromboprophylaxis and obstetric management of the antiphospholipid syndrome
    Gerard Espinosa, Ricard Cervera · 2009 · Expert Opinion on Pharmacotherapy
  52. Thrombotic risk factors in patients with antiphospholipid syndrome: a single center experience
    Ghaith F. Abu-Zeinah, Clara Oromendia, Maria Teresa DeSancho · 2019 · Journal of Thrombosis and Thrombolysis
  53. Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies
    Małgorzata Maria Bała, Elżbieta Paszek, Dorota Włoch-Kopeć, Wiktoria Leśniak, Anetta Undas · 2017 · Cochrane Database of Systematic Reviews
  54. Synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome complicated by seven pulmonary emboli in a 15-year old patient
    Jacquelyn R. Coloe, Stephanie A. Diamantis, Frederick W. Henderson, Dean S. Morrell · 2010 · Journal of the American Academy of Dermatology
  55. Guia de Practica Clinica
    Adopción Les chilena, Lupus Eritematoso, Sistémico, Miguel Á. Malo, Viceministro de Gobernanza · 2013
  56. Reviewing the Recommendations for Lupus in Children
    Zehra Serap Arıcı, Ezgi Deniz Batu, Seza Özen · 2015 · Current Rheumatology Reports
  57. The antiphospholipid syndrome: a large elephant with many parts or an elusive chameleon disguised by many colours?
    Emmanuel J. Favaloro, Richard C. W. Wong · 2010 · Autoimmunity Highlights
  58. Primary antithrombotic prevention in carriers of antiphospholipid antibodies without systemic autoimmune disorders
    Guido Finazzi · 2012 · Lupus
  59. Guidelines for the Primary Prevention of Stroke A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association The American Academy of Neurology affirms the value of these guidelines as an educational tool for neurologists. Endorsed by the American Association of Neurological Surgeons, the Congress of Neurological Surgeons, and the Preventive Cardiovascular Nurses Association
    James Frederick Meschia, Cheryl Bushnell, Bernadette M Boden-Albala, Lynne T. Braun, Dawn M. Bravata, Seemant Chaturvedi, Mark A. Creager, Robert H. Eckel, Myriam Fornage, Larry B. Goldstein et al. · 2014
  60. Management of anticoagulant-refractory thrombotic antiphospholipid syndrome
    Hannah Cohen, Zara Sayar, Maria Efthymiou, Pedro Gaspar, Toby Richards, David Alan Isenberg · 2020 · The Lancet Haematology
  61. Intensity of Warfarin Coagulation in the Antiphospholipid Syndrome
    Mark Andrew Crowther, Mark Andrew Crowther · 2010 · Current Rheumatology Reports
  62. Management of antiphospholipid syndrome
    Nicoletta Del Papa, Nikoleta Vaso · 2010 · Therapeutic Advances in Musculoskeletal Disease
  63. Meta-analysis on aspirin combined with low-molecular-weight heparin for improving the live birth rate in patients with antiphospholipid syndrome and its correlation with d-dimer levels
    Ting Shi, Zhong-Deng Gu, Qizhi Diao · 2021 · Medicine
  64. Dépistage et prise en charge du risque cardiovasculaire au cours du lupus systémique : élaboration de recommandations pour la pratique clinique, à partir d’une analyse de la littérature et de l’avis d’experts
    Laurent Arnaud, Alexis Mathian, D. Adoué, Brigitte Bader‐Meunier, Véronique Baudouin, Cristina C. Belizna, Bernard Bonnotte, Fadia Boumedine, A. Chaïb, Maria Chauchard et al. · 2014 · La Revue de Médecine Interne
  65. Cardiovascular events in patients with antiphospholipid antibodies: Strategies of prevention
    Antonella Tufano, Anna Guida, Matteo Nicola Dario Di Minno, Angela Maria De Gregorio, Anna Maria Cerbone, Giovanni Di Minno · 2010 · Nutrition Metabolism and Cardiovascular Diseases
  66. Prevention of Recurrent Thrombosis in Antiphospholipid Syndrome: Different from the General Population?
    Kimberly Legault, Amaia Ugarte, Mark Andrew Crowther, Guillermo Ruiz‐Irastorza · 2016 · Current Rheumatology Reports
  67. French National Diagnostic and Care Protocol for antiphospholipid syndrome in adults and children
    Zahir Amoura, Brigitte Bader‐Meunier, Claire Bal dit Sollier, Alexandre Bélot, Y. Benhamou, H. Bézanahary, Fleur Cohen Aubart, Nathalie Costedoat-Chalumeau, Luc Darnige, Ludovic O. Drouet et al. · 2023 · La Revue de Médecine Interne
  68. Management of women with systemic lupus erythematosus
    Preeta Kaur Chugh · 2013 · Maturitas
  69. Antiphospholipid Syndrome: Role of Antiphospholipid Antibodies in Neurology
    Rima M. Dafer, José Biller · 2008 · Hematology/Oncology Clinics of North America
  70. Latest advances in connective tissue disorders
    Vijay Rao, Simon Bowman · 2013 · Therapeutic Advances in Musculoskeletal Disease
  71. Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? No
    Guido Finazzi · 2008 · Internal and Emergency Medicine
  72. Systemic Lupus Erythematosus
    Michelle Petri, Martin Aringer, Isabelle M. Ayoub, Salem J. Almaani, Hermine I. Brunner, Maria Dall’Era, Mengdi Jiang, Richard Alan Furie, Jessica M. Greco, Fiona Goldblatt et al. · 2023 · Springer eBooks
  73. Clinical profiles and risk assessment in patients with antiphospholipid antibodies
    Masaru Kato, Ryo Hisada, Tatsuya Atsumi · 2018 · Expert Review of Clinical Immunology
  74. Antiphospholipid syndrome in pediatric patients
    Cristina Tarango, Joseph S. Palumbo · 2019 · Current Opinion in Hematology
  75. Traitement du syndrome des anticorps antiphospholipides
    David Saadoun, J.C. Pietté, Denis G. Wahl, Nathalie Costedoat-Chalumeau · 2012 · La Revue de Médecine Interne
  76. Treatment of thrombotic antiphospholipid syndrome in adults and children
    Jacqueline A. Madison, Alí Duarte‐García, Yu Zuo, Jason S. Knight · 2020 · Current Opinion in Rheumatology
  77. Cardiovascular disease and antiphospholipid syndrome: how to predict and how to treat?
    Ilenia Lorenza Calcaterra, Antonella Tufano, Roberta Lupoli, Gabriella Iannuzzo, Giacomo Emmi, Matteo Nicola Dario Di Minno · 2020 · Polskie Archiwum Medycyny Wewnętrznej
  78. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
    Małgorzata Maria Bała, Magdalena Celińska‐Löwenhoff, Agnieszka Padjas, Wojciech Szot, Anetta Undas · 2016 · Cochrane Database of Systematic Reviews
  79. A importância de reconhecer a síndrome antifosfolípide na medicina vascular
    Andreas Funke, Adriana Danowski, DANIELI CASTRO OLIVEIRA DE ANDRADE, Jozélia Rêgo, Roger A. Levy · 2017 · Jornal Vascular Brasileiro
  80. Wound, pressure ulcer and burn guidelines – 4: Guidelines for the management of connective tissue disease/vasculitis‐associated skin ulcers
    Manabu Fujimoto, Jun Asai, Yoshihide Asano, Takayuki Ishii, Yohei Iwata, Tamihiro Kawakami, Masanari Kodera, Masatoshi Abe, Masahiro Amano, Ryuta Ikegami et al. · 2020 · The Journal of Dermatology
  81. Antiphospholipid antibodies in critical illness
    Francesco Dentali, Mark Andrew Crowther · 2010 · Critical Care Medicine
  82. Current management of antiphospholipid syndrome-related thrombosis
    Dolores Puente, Gonzalo Pombo, Ricardo R Forastiero · 2009 · Expert Review of Cardiovascular Therapy
  83. Antiphospholipid Syndrome
    Ewa Maria Wysokinska, Thomas L. Ortel · 2019 · Elsevier eBooks
  84. Antiphospholipid antibodies and cardiovascular thrombosis
    Sina Rashedi, Hannah Leyva, Saman Asad Siddiqui, Syed Bukhari, Mariana Becker Pfeferman, Nathan W. Watson, Francisco Ujueta, Mehrdad Zarghami, Bassil Bacare, Yogendra M. Kanthi et al. · 2026 · Nature Reviews Cardiology
  85. The ABCs of antiphospholipid syndrome
    Ayşe Bahar Keleşoğlu Dinçer, Doruk Erkan · 2023 · Archives of Rheumatology
  86. Managing CNS involvement in systemic lupus erythematosus
    Matteo Piga, Alessandro Mathieu · 2011 · International Journal of Clinical Rheumatology
  87. Cerebral embolism from libman–sacks endocarditis
    Beatriz Malvar, Filipa Mendonça Almeida, Luisa Rebocho, J Moniz, Francisco Azevedo · 2011 · BMJ Case Reports
  88. Current status and future prospects for the treatment of antiphospholipid syndrome
    Ahlam Al Marzooqi, Alessia Leone, Jamal Al Saleh, Munther A. Khamashta · 2016 · Expert Review of Clinical Immunology
  89. Contraception in Patients with Rheumatic Disease
    Lisa R. Sammaritano · 2017 · Rheumatic Disease Clinics of North America
  90. Treatment in thrombotic antiphospholipid syndrome: a review
    T S Vadgama, A. Smith, María Laura Bertolaccini · 2019 · Lupus
  91. Pathophysiology of Placenta in Antiphospholipid Syndrome
    Anca Vasilica Bobirca, Ana Dumitrache, Cristina Alexandru, Anca Florescu, George Ciobotaru, Florin Teodor BOBIRCA, Romina‐Marina Sima, Cristian Viorel Poalelungi, Mihai Bojincă, I. Ancuta · 2022 · Physiologia
  92. Antiphospholipid antibodies in rheumatoid arthritis: Identifying the dominoes
    Debbie A. Gladd, Ewa Olech · 2009 · Current Rheumatology Reports
  93. Aspirin resistance in systemic lupus erythematosus. A pilot study
    Ali Akdoğan, L Kilic, Ümit Akman, İsmail Doğan, Ömer Karadağ, Ş. A. Bilgen, Yahya Büyükaşık, Sedat Kiraz, İhsan Ertenli · 2013 · Lupus
  94. How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive
    Ian Giles, Anisur Rahman · 2009 · Best Practice & Research Clinical Rheumatology
  95. Superficial femoral artery thrombosis as a cause for distal embolism in primary antiphospholipid syndrome
    Lannery S. Lauvao, Kaoru R. Goshima, Luis R. León, Paul E. Nolan, John Hughes · 2008 · Journal of Vascular Surgery
  96. Repeated miscarriages in patients with antiphospholipid syndrome and subjected to in vitro fertilization: the importance of preimplantation genetic diagnosis
    Zdenka Ulcova-Gallova · 2012 · Lupus
  97. Clinical research in systemic lupus erythematosus: immediate relevance to clinical practice
    Michelle Petri · 2011 · International Journal of Rheumatic Diseases
  98. Role of Direct Oral Anticoagulation Agents as Thromboprophylaxis in Antiphospholipid Syndrome
    Shreya Arora, Shaalina Nair, Rishab Rajendra Prabhu, Chaithanya Avanthika, Sharan Jhaveri, Shilpa Samayam, Maanya Rajasree Katta, Pahel Agarwal · 2021 · Cureus
  99. Grossesse et anticorps antiphospholipides
    Véronique Le Guern, François Goffinet · 2008 · La Presse Médicale
  100. Duration of Anticoagulation Treatment for Thrombosis in APS: Is It Ever Safe to Stop?
    Sinthiya Punnialingam, Munther A. Khamashta · 2013 · Current Rheumatology Reports